Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1583

1.

Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.

Woenckhaus M, Klein-Hitpass L, Grepmeier U, Merk J, Pfeifer M, Wild P, Bettstetter M, Wuensch P, Blaszyk H, Hartmann A, Hofstaedter F, Dietmaier W.

J Pathol. 2006 Oct;210(2):192-204.

PMID:
16915569
2.

Current smoking-specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancer.

Boelens MC, van den Berg A, Fehrmann RS, Geerlings M, de Jong WK, te Meerman GJ, Sietsma H, Timens W, Postma DS, Groen HJ.

J Pathol. 2009 Jun;218(2):182-91. doi: 10.1002/path.2520.

PMID:
19334046
3.

Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.

Kim B, Lee HJ, Choi HY, Shin Y, Nam S, Seo G, Son DS, Jo J, Kim J, Lee J, Kim J, Kim K, Lee S.

Cancer Res. 2007 Aug 1;67(15):7431-8.

4.

Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.

Hofmann HS, Bartling B, Simm A, Murray R, Aziz N, Hansen G, Silber RE, Burdach S.

Oncol Rep. 2006 Sep;16(3):587-95.

PMID:
16865260
5.

Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas.

Fukumoto S, Yamauchi N, Moriguchi H, Hippo Y, Watanabe A, Shibahara J, Taniguchi H, Ishikawa S, Ito H, Yamamoto S, Iwanari H, Hironaka M, Ishikawa Y, Niki T, Sohara Y, Kodama T, Nishimura M, Fukayama M, Dosaka-Akita H, Aburatani H.

Clin Cancer Res. 2005 Mar 1;11(5):1776-85.

6.

Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.

Hirao T, Nelson HH, Ashok TD, Wain JC, Mark EJ, Christiani DC, Wiencke JK, Kelsey KT.

Cancer Res. 2001 Jan 15;61(2):612-5.

7.

Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.

Wikman H, Seppänen JK, Sarhadi VK, Kettunen E, Salmenkivi K, Kuosma E, Vainio-Siukola K, Nagy B, Karjalainen A, Sioris T, Salo J, Hollmén J, Knuutila S, Anttila S.

J Pathol. 2004 May;203(1):584-93.

PMID:
15095482
8.

Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.

Hayashi M, Tokuchi Y, Hashimoto T, Hayashi S, Nishida K, Ishikawa Y, Nakagawa K, Tsuchiya S, Okumura S, Tsuchiya E.

Anticancer Res. 2001 Jan-Feb;21(1B):535-40.

PMID:
11299800
9.

Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.

Yoshimura A, Gemma A, Hosoya Y, Komaki E, Hosomi Y, Okano T, Takenaka K, Matuda K, Seike M, Uematsu K, Hibino S, Shibuya M, Yamada T, Hirohashi S, Kudoh S.

Genes Chromosomes Cancer. 2003 Jun;37(2):159-64.

PMID:
12696064
10.

Methylation discriminators in NSCLC identified by a microarray based approach.

Field JK, Liloglou T, Warrak S, Burger M, Becker E, Berlin K, Nimmrich I, Maier S.

Int J Oncol. 2005 Jul;27(1):105-11.

PMID:
15942649
11.

Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.

Kim JS, Kim H, Shim YM, Han J, Park J, Kim DH.

Carcinogenesis. 2004 Nov;25(11):2165-71. Epub 2004 Jul 1.

PMID:
15231689
12.

Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.

Grepmeier U, Dietmaier W, Merk J, Wild PJ, Obermann EC, Pfeifer M, Hofstaedter F, Hartmann A, Woenckhaus M.

Int J Oncol. 2005 Aug;27(2):481-8.

PMID:
16010431
13.

Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes.

Amatschek S, Koenig U, Auer H, Steinlein P, Pacher M, Gruenfelder A, Dekan G, Vogl S, Kubista E, Heider KH, Stratowa C, Schreiber M, Sommergruber W.

Cancer Res. 2004 Feb 1;64(3):844-56.

14.

Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.

Woenckhaus M, Merk J, Stoehr R, Schaeper F, Gaumann A, Wiebe K, Hartmann A, Hofstaedter F, Dietmaier W.

Hum Pathol. 2008 Jan;39(1):126-36. Epub 2007 Oct 18.

PMID:
17949785
15.

Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.

Sugita M, Geraci M, Gao B, Powell RL, Hirsch FR, Johnson G, Lapadat R, Gabrielson E, Bremnes R, Bunn PA, Franklin WA.

Cancer Res. 2002 Jul 15;62(14):3971-9.

16.

Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.

Pan H, Califano J, Ponte JF, Russo AL, Cheng KH, Thiagalingam A, Nemani P, Sidransky D, Thiagalingam S.

Cancer Res. 2005 Mar 1;65(5):1664-9.

17.

Identification of a transcriptional profile associated with in vitro invasion in non-small cell lung cancer cell lines.

Lader AS, Ramoni MF, Zetter BR, Kohane IS, Kwiatkowski DJ.

Cancer Biol Ther. 2004 Jul;3(7):624-31. Epub 2004 Jul 9.

PMID:
15153803
19.

EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.

Bae NC, Chae MH, Lee MH, Kim KM, Lee EB, Kim CH, Park TI, Han SB, Jheon S, Jung TH, Park JY.

Cancer Genet Cytogenet. 2007 Mar;173(2):107-13.

PMID:
17321325
20.

Detection of K-ras gene mutations in non-neoplastic lung tissue and lung cancers.

Nelson MA, Wymer J, Clements N Jr.

Cancer Lett. 1996 May 15;103(1):115-21.

PMID:
8616804

Supplemental Content

Support Center